New Delhi, Nov 28 (PTI) Dr Reddy's Laboratories on Thursday said it has launched Toripalimab, a drug for the treatment of recurrent or metastatic nasopharyngeal carcinoma in India. Nasopharyngeal ...
Dr. Reddy's launches immuno-oncology drug Toripalimab in India for nasopharyngeal carcinoma, expanding access to innovative treatment.
The museum is refocusing on Indy 500–related cars, so Michael Schumacher's rookie F1 car and the 1965 Le Mans–winning Ferrari ...
Dr Reddy’s Laboratories launches Toripalimab, the first immuno-oncology drug for nasopharyngeal carcinoma, in India.
Nam Cheong has secured multi-year offshore support vessel (OSV) charter contracts worth RM1.22 billion ($368.7 million). The ...
The parade in New York City, presented by department store chain Macy’s, was first held in 1924 under the heading “Macy’s ...
Dr. Reddys has launched Toripalimab, a novel immuno-oncology drug, in India for treating recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). Toripalimab, already approved by USFDA and EMA, will ...
Capital A Bhd posted a net profit of RM1.64bil for the third quarter ended Sept 30, 2024 (3Q24), swinging into the black from ...
Dr. Reddy's Laboratories has announced the launch of Toripalimab in India. This drug is designed to treat adults suffering ...
IHH Healthcare has reported patmi of RM534 million ($161.5 million) for the 3QFY2024 ended September, remaining flat as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback